Patents by Inventor Howard Robin Heyman

Howard Robin Heyman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8426408
    Abstract: The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A1, A2, A3, A4, X and Y are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as aurora and KDR.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: April 23, 2013
    Assignee: AbbVie Inc.
    Inventors: Michael Curtin, Michael R. Michaelides, Howard Robin Heyman, Robin Frey
  • Publication number: 20110275630
    Abstract: Compounds having the formula: are useful for inhibiting protein kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    Type: Application
    Filed: November 3, 2010
    Publication date: November 10, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Mark Matulenko, Tammie Jinkerson, Brian S. Brown, Wilfried Braje, Michael Curtin, Howard Robin Heyman, Victoria Scott, Karen Kage, Steven Cassar, Anil Vasudevan
  • Publication number: 20100317680
    Abstract: The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A1, A2, A3, A4, X and Y are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as aurora and KDR.
    Type: Application
    Filed: June 9, 2010
    Publication date: December 16, 2010
    Applicant: Abbott Laboratories
    Inventors: Michael Curtin, Michael R. Michaelides, Howard Robin Heyman, Robin Frey